Legis Daily

Global COVID-19 Truth, Transparency, and Accountability Act

USA116th CongressHR-6915| House 
| Updated: 5/15/2020
Christopher H. Smith

Christopher H. Smith

Republican Representative

New Jersey

Cosponsors (2)
Mike Johnson (Republican)Henry Cuellar (Democratic)

Foreign Affairs Committee, Budget Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Global COVID-19 Truth, Transparency, and Accountability Act This bill requires assessments of the response of the World Health Organization (WHO) to the COVID-19 (i.e., coronavirus disease 2019) pandemic. The Department of State shall report to Congress on the effectiveness, transparency, and accountability of the WHO's response to the COVID-19 pandemic, including an assessment of information about the pandemic that China conveyed to or withheld from the WHO. The report shall assess whether WHO regulations need to be updated and whether new mechanisms are needed to effectively address pandemics and increase accountability. Materials submitted in support of the President's annual budget shall include an assessment of (1) whether institutional reforms at the WHO are needed to ensure accountability and effectiveness, and (2) whether U.S. contributions to the WHO should be withheld in the absence of such reforms.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 15, 2020
Introduced in House
May 15, 2020
Referred to the Committee on Foreign Affairs, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • May 15, 2020
    Introduced in House


  • May 15, 2020
    Referred to the Committee on Foreign Affairs, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

International Affairs

AsiaBudget processCardiovascular and respiratory healthChinaCongressional oversightEmergency medical services and trauma careExecutive agency funding and structureForeign aid and international reliefGovernment ethics and transparency, public corruptionHealth information and medical recordsHIV/AIDSImmunology and vaccinationInfectious and parasitic diseasesInternational organizations and cooperationMedical tests and diagnostic methodsRule of law and government transparencyUnited NationsU.S. Agency for International Development (USAID)World health

Global COVID-19 Truth, Transparency, and Accountability Act

USA116th CongressHR-6915| House 
| Updated: 5/15/2020
Global COVID-19 Truth, Transparency, and Accountability Act This bill requires assessments of the response of the World Health Organization (WHO) to the COVID-19 (i.e., coronavirus disease 2019) pandemic. The Department of State shall report to Congress on the effectiveness, transparency, and accountability of the WHO's response to the COVID-19 pandemic, including an assessment of information about the pandemic that China conveyed to or withheld from the WHO. The report shall assess whether WHO regulations need to be updated and whether new mechanisms are needed to effectively address pandemics and increase accountability. Materials submitted in support of the President's annual budget shall include an assessment of (1) whether institutional reforms at the WHO are needed to ensure accountability and effectiveness, and (2) whether U.S. contributions to the WHO should be withheld in the absence of such reforms.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 15, 2020
Introduced in House
May 15, 2020
Referred to the Committee on Foreign Affairs, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • May 15, 2020
    Introduced in House


  • May 15, 2020
    Referred to the Committee on Foreign Affairs, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Christopher H. Smith

Christopher H. Smith

Republican Representative

New Jersey

Cosponsors (2)
Mike Johnson (Republican)Henry Cuellar (Democratic)

Foreign Affairs Committee, Budget Committee

International Affairs

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AsiaBudget processCardiovascular and respiratory healthChinaCongressional oversightEmergency medical services and trauma careExecutive agency funding and structureForeign aid and international reliefGovernment ethics and transparency, public corruptionHealth information and medical recordsHIV/AIDSImmunology and vaccinationInfectious and parasitic diseasesInternational organizations and cooperationMedical tests and diagnostic methodsRule of law and government transparencyUnited NationsU.S. Agency for International Development (USAID)World health